| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e72837de81999e7e72cb78d59d19e28 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-174614 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01J49-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-493 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 |
| filingDate |
2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_408baa723bdf44fc25196266f2187d6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3d4c26c4d6d39f0da02a5e75cf4c01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91802ca32a5c60fdf650b230a4964d68 |
| publicationDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010285517-A1 |
| titleOfInvention |
Trimethylamine compounds as risk predictors of cardiovascular disease |
| abstract |
Methods of characterizing a test subject's risk of having or developing cardiovascular disease are provided. The methods include using an analytic device to determine levels of choline-related trimethylamine-containing compounds such as trimethylamine N-oxide, choline, or betaine in a biological sample obtained from the subject and comparing the levels of the choline-related trimethylamine-containing compound in the subject's biological sample to a control value. The test subject's risk of having cardiovascular disease is then characterized as higher if the levels of the choline-related trimethylamine-containing compound are higher than the control value. Also provided are methods of identifying a subject at risk of experiencing a complication of atherosclerotic cardiovascular disease, and methods of evaluating the efficacy of a cardiovascular therapeutic agent in a subject with cardiovascular disease using levels of choline-related trimethylamine-containing compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11703501-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10613044-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11782002-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018004945-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017095975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019070676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9541620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013180961-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3444595-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9535144-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019070678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019152847-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10386355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017095995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020097151-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020097152-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017095993-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9483611-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9483612-B2 |
| priorityDate |
2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |